We observed a significant decline in aSBP on the day participants consumed the high dose of ω-3 PUFA (DHA + EPA), but not placebo, though the difference between the two treatments during the post-dose assessment only approached significance.
← all excerpts
Post-Prandial Cognitive and Blood Pressure Effects of a DHA-Rich Omega-3 Powder in Middle-Aged Males: A Pilot Study.
1
—
—